Publications en collaboration avec des chercheurs de Centro de Investigaciones Energéticas, Medioambientales y Tecnológicas (16)

2024

  1. Modulation of tumor microenvironment by targeting histone acetylation in bladder cancer

    Cell Death Discovery, Vol. 10, Núm. 1

2023

  1. Gene therapy restores the transcriptional program of hematopoietic stem cells in Fanconi anemia

    Haematologica, Vol. 108, Núm. 10, pp. 2652-2663

2022

  1. G9a inhibition by CM-272: Developing a novel anti-tumoral strategy for castration-resistant prostate cancer using 2D and 3D in vitro models

    Biomedicine and Pharmacotherapy, Vol. 150

  2. Generation of NKX2.5GFP Reporter Human iPSCs and Differentiation Into Functional Cardiac Fibroblasts

    Frontiers in Cell and Developmental Biology, Vol. 9

2021

  1. Efficacy and safety of intramuscular administration of allogeneic adipose tissue derived and expanded mesenchymal stromal cells in diabetic patients with critical limb ischemia with no possibility of revascularization: study protocol for a randomized controlled double-blind phase II clinical trial (The NOMA Trial)

    Trials, Vol. 22, Núm. 1

2019

  1. Inhibition of a G9a/DNMT network triggers immune-mediated bladder cancer regression

    Nature Medicine

2015

  1. Generation of a High Number of Healthy Erythroid Cells from Gene-Edited Pyruvate Kinase Deficiency Patient-Specific Induced Pluripotent Stem Cells

    Stem Cell Reports, Vol. 5, Núm. 6, pp. 1053-1066

  2. Interacting resident epicardium-derived fibroblasts and recruited bone marrow cells form myocardial infarction scar

    Journal of the American College of Cardiology, Vol. 65, Núm. 19, pp. 2057-2066

2012

  1. A novel tumor suppressor network in squamous malignancies

    Scientific Reports, Vol. 2

  2. Down-regulated expression of hsa-miR-181c in Fanconi anemia patients: Implications in TNFα regulation and proliferation of hematopoietic progenitor cells

    Blood, Vol. 119, Núm. 13, pp. 3042-3049

  3. EMT and induction of miR-21 mediate metastasis development in Trp53-deficient tumours

    Scientific Reports, Vol. 2

  4. Preclinical activity of LBH589 alone or in combination with chemotherapy in a xenogeneic mouse model of human acute lymphoblastic leukemia

    Leukemia, Vol. 26, Núm. 7, pp. 1517-1526

  5. Unraveling the role of FANCD2 in chronic myeloid leukemia

    Leukemia

2007

  1. Characteristics of lentiviral vectors harboring the proximal promoter of the vav proto-oncogene: A weak and efficient promoter for gene therapy

    Molecular Therapy, Vol. 15, Núm. 8, pp. 1487-1494

2001

  1. Chemokine stromal cell-derived factor-1α modulates VLA-4 integrin-dependent adhesion to fibronectin and VCAM-1 on bone marrow hematopoietic progenitor cells

    Experimental Hematology, Vol. 29, Núm. 3, pp. 345-355

  2. Ex vivo expansion of umbilical cord blood (UCB) CD34+ cells alters the expression and function of α4β1 and α5β1 integrins

    British Journal of Haematology, Vol. 115, Núm. 1, pp. 213-221